Nanotemper Technologies Inc.

South San Francisco, CA

UEI
CPYDZJK1S2K3
CAGE
7P3U8
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
400 Oyster Point Blvd #336, South San Francisco, CA 94080, USA
Founded
2008
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $266,521
FY2025 $13,351
FY2024 -$24,941
FY2023 $778,381

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Commerce $249,134
2 Department of Health and Human Services $17,387

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Nanotemper Technologies Inc., a foreign-owned, self-certified small disadvantaged business headquartered in South San Francisco, California, manufactures and services advanced biophysical analysis instruments for federal research and regulatory agencies as a prime contractor operating exclusively in full-and-open procurements without set-aside designations. The company is a subsidiary of Nanotemper Technologies GMBH, a German parent entity, and specializes in microscale thermophoresis (MST) systems and related analytical equipment used to characterize protein interactions, thermostability, and molecular binding affinity across biomedical research, drug development, and regulatory review workflows.

Nanotemper's customer base concentrates heavily within the Department of Health and Human Services research and regulatory apparatus. The Food and Drug Administration (7 awards, $357 thousand combined potential value), the National Center for Advancing Translational Sciences (4 awards, $281 thousand), and the National Heart Lung and Blood Institute (3 awards, $245 thousand) dominate by award count; by dollar value, the National Institute of Allergy and Infectious Diseases and the National Institute on Drug Abuse rank higher, reflecting larger capital equipment purchases. The top five customer components account for 67% of awards by count and 58% of combined potential value. The National Institute of Standards and Technology and the Centers for Disease Control and Prevention round out active customers. All 27 awards are purchase orders issued directly to Nanotemper as prime; the vendor has no subcontract footprint in the federal space.

Work divides between capital equipment sales and service contracts. Representative prime awards include a $249 thousand NIST purchase order for a Microscale Thermophoresis instrument (August 2026), a $217 thousand National Center for Advancing Translational Sciences purchase for a Prometheus Panta instrument with consumables and on-site training (March 2023), a $197 thousand National Heart Lung and Blood Institute purchase for protein characterization equipment (December 2022), a $164 thousand CDC Pittsburgh purchase for a Monolith X single-molecule force spectroscopy system (September 2023), and multiple repair and maintenance contracts ranging from $12 thousand to $30 thousand with FDA and NCATS. Recent activity shows a contract for instrument repair and restoration with NCATS (September 2026), valued at $29 thousand, with work performed at NIH facilities and return shipment to Nanotemper's German repair facility.

Activity has declined from a 2023 peak of 4 awards to 1 or 2 awards annually in 2024–2026. Combined potential value across all 27 awards totals $3.2 million, with 100% obligated. One award (valued at $30 thousand) completes within the next twenty-four months and faces recompete exposure. NAICS concentration reflects the vendor's core capability: 18 awards under Analytical Laboratory Instrument Manufacturing, 4 under Electronic and Precision Equipment Repair and Maintenance, and smaller volumes in optical and surgical instrument categories. Procurement strategy relies on FAR 12.603 commercial items solicitations rather than competitive task-order vehicles or IDIQs.

Quick answers

Is Nanotemper Technologies Inc. registered in SAM.gov?

Yes. Nanotemper Technologies Inc.'s SAM.gov registration is active through May 15, 2027.

What is Nanotemper Technologies Inc.'s CAGE code?

Nanotemper Technologies Inc.'s CAGE code is 7P3U8, and its Unique Entity ID (UEI) is CPYDZJK1S2K3.

How much has Nanotemper Technologies Inc. received in federal contracts?

Federal contracts obligated $13,351 to Nanotemper Technologies Inc. in fiscal year 2025 and $1,033,312 in fiscal years 2023 through 2027.

What is Nanotemper Technologies Inc.'s most recent federal award?

Nanotemper Technologies Inc.'s most recent federal contract award is Ncats: service: repair and restoration of nanotemper MST instrument: severable (75N98026P01603), from Office of Logisitics and Acquisition Operations (NIH), on September 11, 2026.

On GovTribe

See Nanotemper Technologies Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe